Table 1

Descriptive statistics (mean (SD) or count (%)) on 17 449 patients with type 1 diabetes by categories of BMI at first inclusion in the registry in 2002–2004

VariableAll (n=17 449)<18.5 (n=182)18.5–24.9 (n=9140)25.0–29.9 (n=6330)30.0–35.0 (n=1454)>35.0 (n=343)
Age, years (SD)39.5 (13.2)39.0 (16.7)39.0 (13.6)40.0 (12.5)40.6 (12.3)39.3 (12.7)
Diabetes duration, years (SD)24.0 (13.7)23.2 (17.5)23.8 (14.1)24.5 (13.1)24.0 (13.2)20.7 (13.9)
BMI kg/m² (SD)25.2 (3.8)17.7 (0.8)22.6 (1.6)27.0 (1.4)31.8 (1.4)38.2 (3.7)
Smokers, n (%)2229 (13.5)40 (23.3)1319 (15.2)658 (11.0)183 (13.4)29 (9.3)
Hba1c mmol/mol (SD)64.8 (14.3)69.8 (18.8)64.3 (14.9)64.9 (13.2)66.6 (13.5)66.7 (15.1)
Systolic BP mm Hg (SD)128.4 (16.8)123.2 (20.8)126.5 (16.7)129.9 (16.3)133.4 (16.7)130.4 (17.4)
Diastolic BP mm Hg (SD)73.9 (8.8)71.1 (9.3)72.8 (8.7)74.8 (8.7)76.9 (9.0)76.6 (9.2)
LDL cholesterol mmol/L, (SD)2.8 (0.8)2.6 (0.8)2.7 (0.8)2.9 (0.8)3.0 (0.9)3.0 (0.9)
HDL cholesterol mmol/L, (SD)1.6 (0.5)1.7 (0.4)1.7 (0.5)1.6 (0.4)1.5 (0.4)1.3 (0.4)
Total cholesterol mmol/L, (SD)4.9 (0.9)4.8 (1.1)4.8 (0.9)5.0 (0.9)5.2 (1.0)5.1 (1.0)
Triglycerides mmol/L, (SD)1.2 (0.9)1.2 (0.7)1.0 (0.7)1.2 (0.9)1.5 (1.3)1.9 (1.7)
Creatinine µmol/L (SD)87.7 (49.8)94.3 (72.1)87.6 (52.9)87.6 (41.4)89.6 (60.2)83.6 (46.9)
Microalbuminuria, n (%)2127 (14.8)20 (14.9)1014 (13.4)822 (15.7)214 (18.3)57 (20.5)
Macroalbuminuria, n (%)1363 (8.1)22 (13.6)673 (7.6)484 (8.0)154 (11.2)30 (9.2)
Primary school, n (%)2494 (14.9)32 (20.4)1169 (13.3)986 (16.1)249 (18.0)58 (18.0)
High school, n (%)8449 (50.3)77 (49.0)4191 (47.7)3210 (52.4)770 (55.5)201 (62.2)
University, n (%)5844 (34.8)48 (30.6)3430 (39.0)1934 (31.5)368 (26.5)64 (19.8)
BP medication, n (%)5002 (29.4)38 (21.6)2336 (26.1)1940 (31.5)553 (39.4)135 (40.1)
Lipid medication, n (%)2733 (16.5)23 (13.5)1124 (12.9)1151 (19.1)355 (26.3)80 (24.6)
  • BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein.